Israeli researchers at Hadassah Hospital Ein Kerem have developed a new experimental treatment for multiple myeloma, a blood cancer, with 92 percent of tested-on patients showing positive signs, and over half of them going into complete remission.
The treatment is based on cellular engineering used for treatments of other diseases, and was developed by Professor Cyrille Cohen, head of the Immunology Lab at Bar-Ilan University, in collaboration with Professor Polina Stepansky, director of the Bone Marrow Transplant and Immunotherapy department at Hadassah Medical Center.
Click Here to read the full story on i24News
